Form 8-K - Current report:
SEC Accession No. 0001144204-14-013634
Filing Date
2014-03-06
Accepted
2014-03-06 07:38:56
Documents
7
Period of Report
2014-03-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v370740_8k.htm 8-K 29923
2 EXHIBIT 3.1 v370740_ex3-1.htm EX-3.1 69289
3 EXHIBIT 3.2 v370740_ex3-2.htm EX-3.2 74429
4 EXHIBIT 4.1 v370740_ex4-1.htm EX-4.1 107435
5 EXHIBIT 10.1 v370740_ex10-1.htm EX-10.1 31573
6 EXHIBIT 10.2 v370740_ex10-2.htm EX-10.2 198432
7 EXHIBIT 99.1 v370740_ex99-1.htm EX-99.1 8101
  Complete submission text file 0001144204-14-013634.txt   520608
Mailing Address 12325 EMMET STREET OMAHA NE 68164
Business Address 12325 EMMET ST OMAHA NE 68164 4027385480
TRANSGENOMIC INC (Filer) CIK: 0001043961 (see all company filings)

EIN.: 911789357 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30975 | Film No.: 14671422
SIC: 3826 Laboratory Analytical Instruments